Who owns APIMEDS PHARMACEUTICALS US I COM?
- Ticker: APUS
- CUSIP Number: 03771d102
Tip: Access positions for across all investors
Analyze quarterly positions in Apimeds Pharmaceuticals Us I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apimeds Pharmaceuticals Us I stock
Who bought or sold APIMEDS PHARMACEUTICALS US I COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hemenway Trust Company | 274k | $247k | 0% | Jun 2026 |
|
| Vanguard Capital Management | 64k | $57k | -34% | Jun 2026 |
|
| Geode Capital Management | 35k | $32k | -12% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 24k | $22k | 0% | Jun 2026 |
|
| Jane Street | 16k | $14k | 100% | Jun 2026 |
|
| UBS Group | 12k | $11k | 182% | Jun 2026 |
|
| Tower Research Capital | 1.7k | $1.5k | 100% | Jun 2026 |
|
Who sold out of Apimeds Pharmaceuticals Us I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Mar 2026 | 11k | $19k |